CD8A and neoplasm: Tachykinins also mediate T cell differentiation; Zhang et al. found that CD8+ T cells were significantly decreased after treatment with tachykinin antagonist CD8+ T cells which play crucial roles in cellular immunity, providing protection from tumor cell infiltration.